$CRDF
Cardiff Oncology, Inc. Stock $crdf

$crdf Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000162828018013880 Filed on November 07, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q3
Revenue	$80.00K	$88.36K	$123.3K
YoY Change	-56.76%	-28.35%	38.57%
Cost Of Revenue	$0.00	$26.68K	$473.2K
YoY Change	-100.0%	-94.36%	11.46%
Gross Profit	$80.00K	$61.68K	-$349.9K
YoY Change	-140.0%	-117.63%	4.27%
Gross Profit Margin	100.0%	69.81%	-283.69%
Selling, General & Admin	$1.680M	$1.665M	$4.080M
YoY Change	-9.19%	-59.18%	-27.82%
% of Gross Profit	2100.0%	2699.57%
Research & Development	$2.500M	$1.830M	$1.415M
YoY Change	103.25%	29.39%	-64.07%
% of Gross Profit	3125.0%	2967.45%
Depreciation & Amortization	$160.0K	$220.0K	$310.0K
YoY Change	-44.83%	-29.03%	55.0%
% of Gross Profit	200.0%	356.66%
Operating Expenses	$4.180M	$3.944M	$5.921M
YoY Change	5.32%	-33.39%	-40.87%
Operating Profit	-$4.100M	-$3.855M	-$5.798M
YoY Change	-1.66%	-33.5%	-41.58%
Interest Expense	$110.0K	$16.00	$37.12K
YoY Change	-92.03%	-99.96%	-113.75%
% of Operating Profit
Other Income/Expense, Net	-$170.0K	$2.318K	-$6.541K
YoY Change	0.0%	-135.44%
Pretax Income	-$4.160M	-$3.770M	-$4.290M
YoY Change	61.87%	-12.12%	-57.9%
Income Tax
% Of Pretax Income
Net Earnings	-$4.160M	-$3.770M	-$4.292M
YoY Change	61.87%	-12.17%	-57.89%
Net Earnings / Revenue	-5200.0%	-4266.1%	-3480.09%
Basic Earnings Per Share		-$1.10	-$1.41
Diluted Earnings Per Share	-$1.081M	-$1.10	-$1.41
COMMON SHARES
Basic Shares Outstanding	22.99M shares	3.437M shares	3.039M shares
Diluted Shares Outstanding		3.437M shares	3.039M shares

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.50M	$15.10M	$7.400M
YoY Change	40.24%	104.05%	-84.22%
Cash & Equivalents	$11.45M	$15.07M	$7.434M
Short-Term Investments			$0.00
Other Short-Term Assets	$1.100M	$800.0K	$900.0K
YoY Change	-8.33%	-11.11%	0.0%
Inventory
Prepaid Expenses	$1.144M
Receivables	$167.8K	$128.6K	$178.1K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$12.77M	$16.04M	$8.552M
YoY Change	34.82%	87.61%	-82.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.304M	$1.628M	$3.127M
YoY Change	-46.24%	-47.95%	-32.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$102.8K	$249.6K	$539.3K
YoY Change	-73.64%	-53.71%	45.27%
Total Long-Term Assets	$1.407M	$1.877M	$3.666M
YoY Change	-50.03%	-48.8%	-27.06%
TOTAL ASSETS
Total Short-Term Assets	$12.77M	$16.04M	$8.552M
Total Long-Term Assets	$1.407M	$1.877M	$3.666M
Total Assets	$14.17M	$17.92M	$12.22M
YoY Change	15.36%	46.68%	-76.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$664.8K	$476.3K	$675.5K
YoY Change	-19.44%	-29.49%	-26.99%
Accrued Expenses	$1.772M	$1.718M	$2.620M
YoY Change	21.81%	-34.43%	-42.52%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00	$1.500M
YoY Change		-100.0%	87.5%
Total Short-Term Liabilities	$2.923M	$2.667M	$5.082M
YoY Change	-25.91%	-47.53%	-22.59%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$42.00K	$1.300M	$3.200M
YoY Change	-97.67%	-59.38%	-21.95%
Total Long-Term Liabilities	$42.00K	$1.300M	$3.200M
YoY Change	-97.67%	-59.38%	-83.76%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.923M	$2.667M	$5.082M
Total Long-Term Liabilities	$42.00K	$1.300M	$3.200M
Total Liabilities	$4.088M	$3.941M	$8.273M
YoY Change	-29.25%	-52.36%	-68.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$192.2M	-$188.0M	-$170.5M
YoY Change	11.06%	10.3%	22.15%
Common Stock	$7.742K	$7.738K	$3.811K
YoY Change	46.66%	103.04%	24.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.08M	$13.98M	$3.945M
YoY Change
Total Liabilities & Shareholders Equity	$14.17M	$17.92M	$12.22M
YoY Change	15.36%	46.68%	-76.95%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	-$4.160M	-$3.770M	-$4.292M
YoY Change	61.87%	-12.17%	-57.89%
Depreciation, Depletion And Amortization	$160.0K	$220.0K	$310.0K
YoY Change	-44.83%	-29.03%	55.0%
Cash From Operating Activities	-$3.610M	-$3.480M	-$6.590M
YoY Change	8.41%	-47.19%	-6.52%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	-$120.0K
YoY Change	-100.0%	-100.0%	-7.69%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$60.00K	$0.00
YoY Change			-100.0%
Cash From Investing Activities	$0.00	$60.00K	-$110.0K
YoY Change	-100.0%	-154.55%	-103.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	6.370M
YoY Change	-100.0%	-100.0%	74.04%
NET CHANGE
Cash From Operating Activities	-3.610M	-3.480M	-6.590M
Cash From Investing Activities	0.000	60.00K	-110.0K
Cash From Financing Activities	0.000	0.000	6.370M
Net Change In Cash	-3.610M	-3.420M	-330.0K
YoY Change	-568.83%	936.36%	1550.0%
FREE CASH FLOW
Cash From Operating Activities	-$3.610M	-$3.480M	-$6.590M
Capital Expenditures	$0.00	$0.00	-$120.0K
Free Cash Flow	-$3.610M	-$3.480M	-$6.470M
YoY Change	7.12%	-46.21%	-6.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001213037
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22990942	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Registrant Name EntityRegistrantName	Trovagene, Inc.
CY2017Q3	trov	Adjustment For Change In Unrealized Gain Loss On Derivatives AdjustmentForChangeInUnrealizedGainLossOnDerivatives	0	USD
	trov	Adjustment For Change In Unrealized Gain Loss On Derivatives AdjustmentForChangeInUnrealizedGainLossOnDerivatives	0	USD
CY2018Q3	trov	Adjustment For Change In Unrealized Gain Loss On Derivatives AdjustmentForChangeInUnrealizedGainLossOnDerivatives	0	USD
	trov	Adjustment For Change In Unrealized Gain Loss On Derivatives AdjustmentForChangeInUnrealizedGainLossOnDerivatives	0	USD
	trov	Amortized Portion Of Final Fee Upon Repayment AmortizedPortionOfFinalFeeUponRepayment	293614	USD
	trov	Amortized Portion Of Final Fee Upon Repayment AmortizedPortionOfFinalFeeUponRepayment	0	USD
	trov	Class Of Warrant Or Right Number Exercised ClassOfWarrantOrRightNumberExercised	447108	shares
	trov	Class Of Warrant Or Right Number Granted ClassOfWarrantOrRightNumberGranted	20700000	shares
	us-gaap	Interest Expense InterestExpense	25177	USD
	trov	Diagnostic Service Revenue DiagnosticServiceRevenue	142482	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	9468687	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	16043572	USD
	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	-6400	USD
	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	0	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13915094	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7434298	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8225764	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15065913	USD
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1936641	shares
CY2018Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	22189533	shares
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	18180	USD
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4399299	shares
CY2017	trov	Class Of Warrant Or Right Term Of Outstanding Warrants Or Rights ClassOfWarrantOrRightTermOfOutstandingWarrantsOrRights	P4Y4M21D
	trov	Class Of Warrant Or Right Term Of Outstanding Warrants Or Rights ClassOfWarrantOrRightTermOfOutstandingWarrantsOrRights	P4Y7M13D
CY2017Q4	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	11.34
CY2018Q3	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	1.94
	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExercised	3.60
	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Granted ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsGranted	1.10
CY2017Q3	trov	Comprehensive Income Loss Availableto Common Stockholders Basic ComprehensiveIncomeLossAvailabletoCommonStockholdersBasic	-4299570	USD
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22957192	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4399299	shares
	trov	Comprehensive Income Loss Availableto Common Stockholders Basic ComprehensiveIncomeLossAvailabletoCommonStockholdersBasic	-22359915	USD
CY2018Q3	trov	Comprehensive Income Loss Availableto Common Stockholders Basic ComprehensiveIncomeLossAvailabletoCommonStockholdersBasic	-3775628	USD
	trov	Comprehensive Income Loss Availableto Common Stockholders Basic ComprehensiveIncomeLossAvailabletoCommonStockholdersBasic	-15090413	USD
CY2017Q3	trov	Deemed Dividend Related To Beneficial Conversion Feature Of Preferred Stock DeemedDividendRelatedToBeneficialConversionFeatureOfPreferredStock	0	USD
	trov	Deemed Dividend Related To Beneficial Conversion Feature Of Preferred Stock DeemedDividendRelatedToBeneficialConversionFeatureOfPreferredStock	0	USD
CY2018Q3	trov	Deemed Dividend Related To Beneficial Conversion Feature Of Preferred Stock DeemedDividendRelatedToBeneficialConversionFeatureOfPreferredStock	0	USD
	trov	Deemed Dividend Related To Beneficial Conversion Feature Of Preferred Stock DeemedDividendRelatedToBeneficialConversionFeatureOfPreferredStock	2769533	USD
CY2017Q3	trov	Diagnostic Service Revenue DiagnosticServiceRevenue	58119	USD
CY2018Q3	trov	Diagnostic Service Revenue DiagnosticServiceRevenue	4303	USD
	trov	Diagnostic Service Revenue DiagnosticServiceRevenue	83650	USD
	trov	Operating Lease Monthly Rent OperatingLeaseMonthlyRent	73000	USD
	trov	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	18180	USD
	trov	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	18180	USD
	trov	Sale Of Stock Value Common And Warrants Net SaleOfStockValueCommonAndWarrantsNet	-11779525	USD
	trov	Stock Issued During Period Value Warrants Exercised Net StockIssuedDuringPeriodValueWarrantsExercisedNet	1612667	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	825244	USD
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	476300	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	77095	USD
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	128577	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-9230	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1454587	USD
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1718060	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2071492	USD
CY2018Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2352005	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	179546954	USD
CY2018Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	201998634	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1905652	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1421180	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3117364	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	278221	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1905652	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	113780	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1214165	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	22909912	shares
CY2018Q3	us-gaap	Area Of Land AreaOfLand	26100	sqft
CY2017Q4	us-gaap	Assets Assets	12284941	USD
CY2018Q3	us-gaap	Assets Assets	17920822	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4293510	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-22341735	USD
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22957192	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	5279	USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	7738	USD
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	52000	USD
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3769568	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12302700	USD
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	USD
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	886	USD
CY2017Q3	us-gaap	Cost Of Revenue CostOfRevenue	473202	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1427831	USD
CY2018Q3	us-gaap	Cost Of Revenue CostOfRevenue	26677	USD
	us-gaap	Cost Of Revenue CostOfRevenue	597457	USD
CY2017Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	334424	USD
CY2018Q3	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	472251	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1183677	USD
CY2018Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1204109	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	956995	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	701774	USD
CY2017Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	649387	USD
CY2018Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	70347	USD
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.41
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.17
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.38
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.41
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.17
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.38
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-8837	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-28199	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-197490	USD
CY2017Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1655825	USD
CY2018Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	17974	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	800	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	800	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1908796	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	383037	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	77667	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-58440	USD
	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	90330	USD
	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	0	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	207435	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	266556	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	170602	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-18230	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-316746	USD
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2017Q3	us-gaap	Interest Expense InterestExpense	37123	USD
CY2018Q3	us-gaap	Interest Expense InterestExpense	16	USD
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-13486	USD
	us-gaap	Interest Expense InterestExpense	1010256	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	0	USD
CY2017Q3	us-gaap	Interest Income Operating InterestIncomeOperating	20650	USD
	us-gaap	Interest Income Operating InterestIncomeOperating	132515	USD
CY2018Q3	us-gaap	Interest Income Operating InterestIncomeOperating	85938	USD
	us-gaap	Interest Income Operating InterestIncomeOperating	143911	USD
	us-gaap	Interest Paid InterestPaid	650331	USD
	us-gaap	Interest Paid InterestPaid	22482	USD
CY2017Q4	us-gaap	Liabilities Liabilities	5778834	USD
CY2018Q3	us-gaap	Liabilities Liabilities	3941067	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12284941	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17920822	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3945770	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2666611	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1331515	USD
CY2018Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	0	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-6480796	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	6840149	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-10447842	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	16403540	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	23925535	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	22842	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-19949652	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-9586233	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-4291966	USD
	us-gaap	Net Income Loss NetIncomeLoss	-22337314	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-3769568	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12302700	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4298026	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22355494	USD
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3775628	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15090413	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4298026	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-22355494	USD
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3775628	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-15090413	USD
	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification	109922	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	5920950	USD
	us-gaap	Operating Expenses OperatingExpenses	22131898	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	3943669	USD
	us-gaap	Operating Expenses OperatingExpenses	13250237	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5797621	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-21811520	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3855308	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12949927	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	389942	USD
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	249645	USD
CY2017Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1544	USD
CY2018Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	0	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1544	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4421	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	9065	USD
CY2018Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6541	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4975	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2318	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-68521	USD
CY2017Q3	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	6431	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	8481	USD
CY2018Q3	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	11490	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	42614	USD
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	1613067	USD
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	175381	USD
CY2018Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1800000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	8804604	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	31500	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	136251	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5100	USD
CY2017Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	6060	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	18180	USD
CY2018Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	6060	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	18180	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	60	USD
CY2018Q3	us-gaap	Preferred Stock Value PreferredStockValue	60	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1165828	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	849082	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6634803	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11779525	USD
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	0	USD
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	4386762	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	16431837	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	0	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	16434553	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	31500	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	27942	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1612667	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4497804	USD
CY2018Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3979610	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2426312	USD
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	485000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1627605	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	15000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	469578	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	1200033	USD
CY2017Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1414706	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	6676251	USD
CY2018Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1830441	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	5667046	USD
CY2017Q3	us-gaap	Restructuring Charges RestructuringCharges	-46472	USD
	us-gaap	Restructuring Charges RestructuringCharges	1700000	USD
	us-gaap	Restructuring Charges RestructuringCharges	1669526	USD
CY2018Q3	us-gaap	Restructuring Charges RestructuringCharges	421351	USD
	us-gaap	Restructuring Charges RestructuringCharges	664686	USD
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	187500	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-173046186	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-188026677	USD
CY2017Q3	us-gaap	Royalty Revenue RoyaltyRevenue	58779	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	169415	USD
CY2018Q3	us-gaap	Royalty Revenue RoyaltyRevenue	72568	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	174046	USD
CY2017Q3	us-gaap	Sales Revenue Net SalesRevenueNet	123329	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	320378	USD
CY2018Q3	us-gaap	Sales Revenue Net SalesRevenueNet	88361	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	300310	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4079514	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12358290	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1665200	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6321048	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3117364	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1905652	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3378243	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1515946	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4386762	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	6506107	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	13979755	USD
CY2017Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	1528669	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2012747	USD
CY2018Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-2500	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	579040	USD
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3038806	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2735526	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20622660	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10945249	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3038806	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2735526	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20622660	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10945249	shares

Files In Submission

Name	View Source	Status
0001628280-18-013880-index-headers.html	Edgar Link	pending
0001628280-18-013880-index.html	Edgar Link	pending
0001628280-18-013880.txt	Edgar Link	pending
0001628280-18-013880-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trov-093018exhibit311.htm	Edgar Link	pending
trov-093018exhibit321.htm	Edgar Link	pending
trov-093018x10q.htm	Edgar Link	pending
trov-20180930.xml	Edgar Link	completed
trov-20180930.xsd	Edgar Link	pending
trov-20180930_cal.xml	Edgar Link	unprocessable
trov-20180930_def.xml	Edgar Link	unprocessable
trov-20180930_lab.xml	Edgar Link	unprocessable
trov-20180930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRDF
Cardiff Oncology, Inc. Stock $crdf

2018 Q4 Form 10-Q Financial Statement

#000162828018013880 Filed on November 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRDF Cardiff Oncology, Inc. Stock $crdf

2018 Q4 Form 10-Q Financial Statement

#000162828018013880 Filed on November 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRDF
Cardiff Oncology, Inc. Stock $crdf